'It's not over when it's over': Persistent neurobiological abnormalities in recovered depressed patients

Psychological Medicine

Volumn 38, Issue 3, 2008, Pages 307-313

  Bhagwagar, Z ^a   Cowen, P J ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Depression; GABA; HPA axis; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; HYDROCORTISONE; METIROSINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN;

COGNITIVE THERAPY; ELECTROCONVULSIVE THERAPY; HUMAN; HYDROCORTISONE RELEASE; MAJOR DEPRESSION; MONOAMINERGIC SYSTEM; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROLOGIC DISEASE; NEUROPSYCHOLOGY; NEUROTRANSMISSION; RECURRENT DISEASE; REM SLEEP; REVIEW; RISK FACTOR; SLEEP PATTERN;

ACUTE DISEASE; DEPRESSIVE DISORDER; DEXAMETHASONE; ELECTROCONVULSIVE THERAPY; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RECURRENCE; SALIVA; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION;

EID: 39749151066     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291707001250     Document Type: Review

References (61)

1. Angst J (2000). Course and prognosis of mood disorders. In New Oxford Textbook of Psychiatry (ed. M. G. Gelder, J. J. Lopez-Ibor and N. C. Andreasen), pp. 719-724. Oxford University Press: New York.
2. Berman RM, Narasimhan M, Miller HL, Anand A, Cappiello A, Oren DA, Heninger GR, Charney DS (1999). Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker? Archives of General Psychiatry 56, 395-403.
3. Bhagwagar Z, Cowen PJ, Goodwin G, Harmer CJ (2004b). Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. American Journal of Psychiatry 161, 166-168.
4. Bhagwagar Z, Hafizi S, Cowen PJ (2003). Increase in concentration of waking salivary cortisol in recovered patients with depression. American Journal of Psychiatry 160, 1890-1891.
5. Bhagwagar Z, Hafizi S, Cowen PJ (2005). Increased salivary cortisol after waking in depression. Psychopharmacology 182, 54-57.
6. 11C]MDL 100,907. American Journal of Psychiatry 163, 1580-1587.
7. 11C]WAY-100635. Molecular Psychiatry 9, 386-392.
8. Bhagwagar Z, Wyleszinska M, Jezzard P, Evans J, Ashworth F, Sule A, Matthews PM, Cowen PJ (2007). Reduction in occipital cortex c-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biological Psychiatry 61, 808-812.
9. Bremner JD, Vythilingam M, Ng CK, Vermetten E, Nazeer A, Oren A, Berman RM, Charney DS (2003). Regional brain metabolic correlates of α-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. Journal of the American Medical Association 289, 3125-3134.
10. Campbell S, MacQueen G (2004). The role of the hippocampus in the pathophysiology of major depression. Journal of Psychiatry and Neuroscience 29, 417-426.
11. Campbell S, MacQueen G (2006). An update on regional brain volume differences associated with mood disorders. Current Opinion in Psychiatry 19, 25-33.
12. Cowen PJ (2005). Neurobiology of depression. In Mood Disorders: Clinical Management and Research Issues (ed. E. J. Griez, C. Faravelli, D. J. Nutt and J. Zohar), pp. 191-210. Wiley: Oxford.
13. Del-Ben CM, Deakin JFW, McKie S, Delvai NS, Williams SR, Elliott R, Dolan M, Anderson IM (2005). The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an fMRI study. Neuropsychopharmacology 30, 1723-1734.
14. Drevets WC (2003). Neuroimaging abnormalities in the amygdala in mood disorder. Annals of the New York Academy of Sciences 985, 420-444.
15. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C (1999). PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry 46, 1357-1387.
16. 1A-mediated autoregulation predicts amygdala reactivity. Nature Neuroscience 9, 1362-1363.
17. Flint J, Munafò MR (2007). The endophenotype concept in psychiatric genetics. Psychological Medicine 37, 163-180.
18. Fu CHY, Williams SCR, Cleare AJ, Brammer MJ, Walsh MD, Kim J, Andrew CM, Williams PM, Reed LJ, Mitterschiffthaler MT, Suckling J, Bullmore ET (2004). Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Archives of General Psychiatry 61, 877-889.
19. Giles DE, Jarrett RB, Rush AJ, Roffwarg HP (1993). Prospective assessment of electroencephalographic sleep in remitted major depression. Psychiatry Research 46, 269-284.
20. Giles DE, Kupfer DJ, Rush AJ, Roffwarg HP (1998). Controlled comparison of electrophysiological sleep in families of probands with unipolar depression. American Journal of Psychiatry 155, 192-199.
21. Goodyer IM, Herbert J, Tamplin A, Altham PM (2000). Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. British Journal of Psychiatry 177, 499-504.
22. Halligan SL, Herbert J, Goodyer I, Murray L (2007). Disturbances in morning cortisol secretion in association with maternal postnatal depression predict subsequent depressive symptomatology in adolescents. Biological Psychiatry 62, 40-46.
23. Harris TO, Borsanyi S, Messari S, Stanford K, Cleary SE, Shiers HM, Brown GW, Herbert J (2000). Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. British Journal of Psychiatry 177, 505-510.
24. Harrison PJ (2002). The neuropathology of primary mood disorder. Brain 125, 1428-1449.
25. Hasler G, Drevets WC, Manji HK, Charney DS (2004). Discovering endophenotypes for major depression. Neuropsychopharmacology 29, 1765-1781.
26. Holsboer F (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477-501.
27. Holsboer F, Lauer CJ, Schreiber W, Krieg J-C (1995). Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62, 340-347.
28. Ising M, Lauer CJ, Holsboer F, Modell S (2005). The Munich vulnerability study on affective disorders: premorbid neuroendocrine profile of affected high-risk probands. Journal of Psychiatric Research 39, 21-28.
29. Johnson-Laird PN, Mancini F, Gangemi A (2006). A hyperemotion theory of psychological illness. Psychological Reviews 113, 822-841.
30. Kendler KS, Thorton LM, Gardner CO (2001). Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. American Journal of Psychiatry 158, 582-586.
31. Lee AS, Murray RM (1988). The long-term outcome of Maudsley depressives. British Journal of Psychiatry 153, 741-751.
32. Lee JL, Milton AL, Everitt BJ (2006). Reconsolidation and extinction of conditioned fear: inhibition and potentiation. Journal of Neuroscience 26, 10051-10056.
33. Mannie ZN, Harmer CJ, Cowen PJ (2007). Increased waking salivary cortisol in young people at increased familial risk of depression. American Journal of Psychiatry 164, 617-621.
34. Martin-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G, Artigas F (2001). Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. Journal of Neuroscience 21, 9856-9866.
35. McTavish SFB, Cowen PJ, Sharp T (1996). Effect of tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology 141, 182-188.
36. McTavish SFB, Mannie ZN, Harmer CJ, Cowen PJ (2005). Lack of effect of tyrosine depletion on mood in recovered depressed women. Neuropsychopharmacology 30, 786-911.
37. Meyer J, McMain S, Kennedy SH, Korman L, Brown GM, DaSilva JN, Wilson AA (2003). Dysfunctional attitudes and 5-HT receptors during depression and self harm. American Journal of Psychiatry 160, 60-90.
38. Mintun MA, Sheline YI, Moerlein SM, Vlassenko AG, Huang Y, Snyder AZ (2004). Decreased hippocampal 5-HT receptor binding in major depressive disorder: in vivo measurement with [F]altansarin positron emission tomography. Biological Psychiatry 55, 217-224.
39. Modell S, Ising M, Holsboer F, Lauer CJ (2005). The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands. Biological Psychiatry 58, 694-699.
40. Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Corywell W, Warshaw M, Maser JD (1999). Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. American Journal of Psychiatry 156, 1000-1006.
41. 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology 31, 1750-1756.
42. Neumeister A, Nugent AC, Waldeck T, Geraci M, Schwarz M, Bonne O, Bain EE, Luckenbaugh DA, Herscovitch P, Charney DS, Drevets WC (2004). Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Archives of General Psychiatry 61, 765-773.
43. Phillips ML, Drevets WC, Rauch SL, Lane R (2003). Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biological Psychiatry 54, 504-514.
44. Piquet P, Galvan M (1994). Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro. Journal of Physiology 481, 629-639.
45. Pruessner JC, Wolf OT, Hellhammer DH, Buske-Kirschbaum A, von-Auer K, Jobst S, Kirschbaum C (1997). Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocorticol activity. Life Sciences 61, 2539-2549.
46. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, Mann JJ, Brunner D (1998). Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Sciences USA 95, 14476-14481.
47. Ruhé HG, Mason NS, Schene AH (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Molecular Psychiatry 12, 331-359.
48. Sanacora G, Fenton LR, Fasula MK, Rothman DL, Levin Y, Krystal JH, Mason GF (2006). Cortical γ-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy. Biological Psychiatry 59, 284-286.
49. Sanacora G, Gueorguiva R, Epperson CN, Wu YT, Appel M, Rothman DL (2004). Subtype-specific alterations of γ-aminobutyric acid and glutamate in patients with major depression. Archives of General Psychiatry 61, 705-713.
50. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB (2003). Increased cortical GABA concentrations in depressed patients receiving ECT. American Journal of Psychiatry 160, 577-579.
51. Sanacora G, Mason GF, Rothman DL, Krystal JH (2002). Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. American Journal of Psychiatry 159, 663-665.
52. 11C]WAY-100635: effects of depression and antidepressant treatment. Archives of General Psychiatry 57, 174-180.
53. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA (2001). Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biological Psychiatry 50, 651-658.
54. Sherwood B, Varghese FP, McEwen BS (2004). Association of depression with medical illness: does cortisol play a role? Biological Psychiatry 55, 1-9.
55. Smith KA, Fairburn CG, Cowen PJ (1997). Relapse of depression after rapid depletion of tryptophan. Lancet 349, 915-919.
56. Smith KA, Morris JS, Friston KJ, Cowen PJ, Dolan RJ (1999). Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. British Journal of Psychiatry 174, 525-529.
57. Stutzmann GE, LeDoux JE (1999). Gabaergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. Journal of Neuroscience RC8, 1-4.
58. Styron W (2004). Darkness Visible. Vintage Classics: London.
59. Taylor M, Bhagwagar Z, Cowen PJ, Sharp T (2003). GABA and mood disorders. Psychological Medicine 33, 387-393.
60. Vuillemier P (2005). How brains beware: neural mechanisms of emotional attention. Trends in Cognitive Sciences 9, 585-594.
61. Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer FI, Sing M (2001). Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study. Journal of Psychiatric Research 35, 83-94.